SK165596A3 - Sterol derivatives used for regulation of meiosis in the mammalian zygotes - Google Patents

Sterol derivatives used for regulation of meiosis in the mammalian zygotes Download PDF

Info

Publication number
SK165596A3
SK165596A3 SK1655-96A SK165596A SK165596A3 SK 165596 A3 SK165596 A3 SK 165596A3 SK 165596 A SK165596 A SK 165596A SK 165596 A3 SK165596 A3 SK 165596A3
Authority
SK
Slovakia
Prior art keywords
formula
group
sterol derivatives
carbon atoms
miosis
Prior art date
Application number
SK1655-96A
Other languages
English (en)
Slovak (sk)
Inventor
Anne G Byskov
Claus Y Andersen
Lars Nordholm
Henning Thogersen
Ole Wassmann
Ivan V Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of SK165596A3 publication Critical patent/SK165596A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1655-96A 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis in the mammalian zygotes SK165596A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (1)

Publication Number Publication Date
SK165596A3 true SK165596A3 (en) 1997-08-06

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1655-96A SK165596A3 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis in the mammalian zygotes

Country Status (26)

Country Link
US (1) US5716777A (fi)
EP (1) EP0767798B1 (fi)
JP (1) JP3987105B2 (fi)
KR (1) KR100408369B1 (fi)
CN (1) CN1068333C (fi)
AT (1) ATE248852T1 (fi)
AU (1) AU694240B2 (fi)
BG (1) BG101067A (fi)
BR (1) BR9508074A (fi)
CA (1) CA2192941C (fi)
CZ (1) CZ289407B6 (fi)
DE (1) DE69531682T2 (fi)
DK (1) DK0767798T3 (fi)
ES (1) ES2204955T3 (fi)
FI (1) FI117159B (fi)
HU (1) HUT76343A (fi)
IL (1) IL114294A (fi)
IS (1) IS4404A (fi)
MX (1) MX9700174A (fi)
NO (1) NO314534B1 (fi)
PL (1) PL186688B1 (fi)
RU (1) RU2194510C2 (fi)
SI (1) SI9520077A (fi)
SK (1) SK165596A3 (fi)
UA (1) UA51622C2 (fi)
WO (1) WO1996000235A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
CN1191543A (zh) * 1995-06-23 1998-08-26 诺沃挪第克公司 减数分裂调控化合物
EP0946584B1 (en) 1996-12-20 2003-04-23 Novo Nordisk A/S Meiosis regulating compounds
HUP0002331A3 (en) * 1997-05-16 2001-05-28 Akzo Nobel Nv 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
EP0988312B1 (en) * 1997-06-04 2002-04-03 Akzo Nobel N.V. 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
ES2181321T3 (es) 1997-12-18 2003-02-16 Akzo Nobel Nv Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
AU3701199A (en) * 1998-05-13 1999-11-29 Novo Nordisk A/S Meiosis regulating compounds
KR20010043558A (ko) * 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
KR20010043828A (ko) * 1998-05-26 2001-05-25 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법
JP2003521444A (ja) * 1998-06-19 2003-07-15 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
AU759344B2 (en) * 1998-12-11 2003-04-10 Akzo Nobel N.V. 22S-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
KR20010101820A (ko) * 1999-02-10 2001-11-14 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
KR20010093280A (ko) 1999-02-24 2001-10-27 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 불임증 치료
ATE361091T1 (de) * 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit
IL144529A0 (en) * 1999-02-26 2002-05-23 Novo Nordisk As Meiosis activating sterol augments implantation rate
ES2188515T3 (es) * 1999-03-09 2003-07-01 Akzo Nobel Nv Derivados de 22r-hidroxicolesta-8,14-dieno con actividad inhibidora de la meiosis.
KR100757909B1 (ko) * 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ｉｖｆ를 위한 조성물
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
MXPA02007818A (es) * 2000-02-25 2002-10-23 Schering Ag Tasa de implantacion mejorada utilizando ff-mas.
WO2001088098A2 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
JPH10502060A (ja) 1998-02-24
FI117159B (fi) 2006-07-14
CA2192941A1 (en) 1996-01-04
IS4404A (is) 1996-12-23
NO314534B1 (no) 2003-04-07
MX9700174A (es) 1997-04-30
AU694240B2 (en) 1998-07-16
AU2734395A (en) 1996-01-19
NO965516D0 (no) 1996-12-20
DE69531682T2 (de) 2004-07-15
DK0767798T3 (da) 2003-12-22
FI965144A0 (fi) 1996-12-20
ATE248852T1 (de) 2003-09-15
FI965144A (fi) 1997-02-20
CZ372596A3 (en) 1997-07-16
CN1151164A (zh) 1997-06-04
CZ289407B6 (cs) 2002-01-16
IL114294A (en) 2002-09-12
WO1996000235A1 (en) 1996-01-04
BG101067A (en) 1997-08-29
DE69531682D1 (de) 2003-10-09
CN1068333C (zh) 2001-07-11
HU9603584D0 (en) 1997-02-28
JP3987105B2 (ja) 2007-10-03
HUT76343A (en) 1997-08-28
RU2194510C2 (ru) 2002-12-20
EP0767798A1 (en) 1997-04-16
PL317830A1 (en) 1997-04-28
BR9508074A (pt) 1997-08-12
KR100408369B1 (ko) 2004-04-28
US5716777A (en) 1998-02-10
EP0767798B1 (en) 2003-09-03
ES2204955T3 (es) 2004-05-01
IL114294A0 (en) 1995-10-31
SI9520077A (sl) 1998-06-30
NO965516L (no) 1997-02-21
PL186688B1 (pl) 2004-02-27
UA51622C2 (uk) 2002-12-16
CA2192941C (en) 2009-04-14

Similar Documents

Publication Publication Date Title
SK165596A3 (en) Sterol derivatives used for regulation of meiosis in the mammalian zygotes
EP0857173B1 (en) Meiosis regulating compounds
US6486145B2 (en) Meiosis regulating compounds
EP0414606B1 (fr) Nouveaux acides oméga-phénylamino alcanoiques substitués sur le noyau aromatique par un radical dérivé de 19-nor stéroides, leurs sels, leur procédé de préparation et les intermédiaires de ce procédé, leur application à titre de médicaments et les compositions les renfermant
US20030004148A1 (en) Regulation of meiosis
RU2349597C2 (ru) Тиоморфолиновые производные стероидов, их применение для получения регулирующих мейоз лекарственных средств и способ получения этих соединений
KR20020013541A (ko) 14β-Ｈ-스테롤, 그를 포함하는 제약 조성물, 및 감수분열조절 약제 제조에 있어서 그의 유도체의 용도
MXPA06001145A (en) Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis-regulating medicaments and method for the preparation thereof
KR20010101820A (ko) 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
MXPA98000123A (en) Compounds that regulate the meio
JP2002532511A (ja) 減数分裂調節活性を有する２２ｓ−ヒドロキシコレスタ−８，１４−ジエン誘導体
CZ291308B6 (cs) Sterolové deriváty regulující meiózu a způsob regulace